CL2010001441A1 - Proceso para la preparacion de derivados de 2-amino tiazolonas sustituidas utilizando derivados de efedrina como base quiral. - Google Patents

Proceso para la preparacion de derivados de 2-amino tiazolonas sustituidas utilizando derivados de efedrina como base quiral.

Info

Publication number
CL2010001441A1
CL2010001441A1 CL2010001441A CL2010001441A CL2010001441A1 CL 2010001441 A1 CL2010001441 A1 CL 2010001441A1 CL 2010001441 A CL2010001441 A CL 2010001441A CL 2010001441 A CL2010001441 A CL 2010001441A CL 2010001441 A1 CL2010001441 A1 CL 2010001441A1
Authority
CL
Chile
Prior art keywords
derivatives
amino
substituted
preparation
thiazolone
Prior art date
Application number
CL2010001441A
Other languages
English (en)
Inventor
George A Frizzle Matthew J Bernard Charles Martin Elli Michael Faul M Moniz
J Larrow
K Hansen
Klingensmith
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41550939&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2010001441(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CL2010001441A1 publication Critical patent/CL2010001441A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Proceso para preparar compuestos derivados de tiazolonas y 1,3-diazolonas que comprende contactar un compuesto de partida con una base quiral en presencia de un agente deprotonanate y de otro alquilante.
CL2010001441A 2008-06-20 2010-12-15 Proceso para la preparacion de derivados de 2-amino tiazolonas sustituidas utilizando derivados de efedrina como base quiral. CL2010001441A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7434508P 2008-06-20 2008-06-20

Publications (1)

Publication Number Publication Date
CL2010001441A1 true CL2010001441A1 (es) 2011-04-29

Family

ID=41550939

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2010001441A CL2010001441A1 (es) 2008-06-20 2010-12-15 Proceso para la preparacion de derivados de 2-amino tiazolonas sustituidas utilizando derivados de efedrina como base quiral.

Country Status (15)

Country Link
US (1) US8536345B2 (es)
EP (1) EP2303854A2 (es)
JP (1) JP2011524914A (es)
KR (1) KR20110041462A (es)
CN (1) CN102066346A (es)
AU (1) AU2009271404A1 (es)
BR (1) BRPI0915177A2 (es)
CA (1) CA2727674A1 (es)
CL (1) CL2010001441A1 (es)
EA (1) EA018028B1 (es)
IL (1) IL209970A0 (es)
MX (1) MX2010013758A (es)
SG (1) SG192422A1 (es)
WO (1) WO2010008729A2 (es)
ZA (1) ZA201009104B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
KR101897881B1 (ko) 2008-01-04 2018-09-12 인텔리카인, 엘엘씨 특정 화학 물질, 조성물 및 방법
US20130310431A1 (en) 2010-10-15 2013-11-21 Amgen Inc Uses for substituted 2-amino-thiazolones in treating alzheimer's disease
KR101875720B1 (ko) 2011-01-10 2018-07-09 인피니티 파마슈티칼스, 인코포레이티드 이소퀴놀린온 및 이의 고체 형태의 제조 방법
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
US20150320755A1 (en) 2014-04-16 2015-11-12 Infinity Pharmaceuticals, Inc. Combination therapies
CN109640999A (zh) 2016-06-24 2019-04-16 无限药品股份有限公司 组合疗法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407124B1 (en) * 1998-06-18 2002-06-18 Bristol-Myers Squibb Company Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
WO2005116002A2 (en) * 2004-05-24 2005-12-08 Amgen Inc. Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
JP5204662B2 (ja) * 2005-11-22 2013-06-05 アムジエン・インコーポレーテツド １１−β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤
US8541593B2 (en) * 2007-06-21 2013-09-24 Amgen Inc. Process for making substituted 2-amino-thiazolones

Also Published As

Publication number Publication date
WO2010008729A2 (en) 2010-01-21
KR20110041462A (ko) 2011-04-21
IL209970A0 (en) 2011-02-28
EP2303854A2 (en) 2011-04-06
ZA201009104B (en) 2011-09-28
CA2727674A1 (en) 2010-01-21
CN102066346A (zh) 2011-05-18
WO2010008729A3 (en) 2010-05-06
SG192422A1 (en) 2013-08-30
EA201170057A1 (ru) 2011-08-30
MX2010013758A (es) 2011-03-02
US20110160463A1 (en) 2011-06-30
EA018028B1 (ru) 2013-04-30
US8536345B2 (en) 2013-09-17
JP2011524914A (ja) 2011-09-08
AU2009271404A1 (en) 2010-01-21
BRPI0915177A2 (pt) 2016-04-26

Similar Documents

Publication Publication Date Title
CL2010001441A1 (es) Proceso para la preparacion de derivados de 2-amino tiazolonas sustituidas utilizando derivados de efedrina como base quiral.
NO20171811A1 (no) Fremgangsmåte for fremstilling av (1R,2R)-3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol
UY32049A (es) Inhibidores de cmet
BRPI0915728A2 (pt) composição enzimática, processo para preparar a composição, uso da composição enzimática, e, composição detergente.
BRPI0807756A2 (pt) Método para produzir um l-aminoácido.
BRPI1006162A2 (pt) "composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto".
BRPI0922742A2 (pt) adesivo ou selante, processo para preparar um adesivo ou selante, e, uso do adesivo ou selante.
DK3309139T3 (da) Process for the preparation of 2,3,3,3-trifluoropropene
BRPI0911898A2 (pt) processo para preparar compostos, e, composto.
BRPI0908252A2 (pt) Processo para preparar um composto, e, uso de um composto
BRPI0908738A2 (pt) composto, medicamento, uso de um composto, e, processo para preparar os compostos
BRPI0923291A2 (pt) processo para a destilação de uma mistura aquosa de polimetilol, composição, e, uso de um polimetilol.
BRPI0816331A2 (pt) Composto, uso de um composto, composição farmacêutica, e, processo para preparar um composto.
CL2011000166A1 (es) Metodo para preparar tetrahidrobiopterina hidrolizando diacetilbiopterina a biopterina en presencia de una base en una mezcla bifasica de agua y solvente organico no miscible en agua e hidrogenando biopterina a tetrahidrobiopterina en presencia de un catalizador, ambas etapas a un ph de al menos 10 (divisional de la solicitud de patente de invencion no. 7-2009).
CL2012002082A1 (es) Proceso para la preparacion de lacosamida, por hidroximetilación; compuestos intermediarios.
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
CR11859A (es) Composición y proceso-356
CR10540A (es) Derivados ciclopropil amina
BRPI1014691A2 (pt) Composto, e, processo para a preparação de um composto.
BRPI0912163A2 (pt) Composto químico, processo para a produção de um composto, compsição química, e, uso de um composto químico.
BRPI0820289A2 (pt) Processo para preparar ácido cianídrico, e, uso de um microevaporador.
IT1395239B1 (it) Procedimento per la produzione di componenti strutturali induriti con procedimenti di riscaldamento di svariati tipi.
ES2572368T3 (es) Tratamiento de la artrosis
BRPI0916847A2 (pt) preparação sólida, e, métodos para estabilizar um composto e para melhorar a propriedade de dissolução de um composto.
BRPI0914924A2 (pt) processo para preparar aminobifenilas, e, composto.